Lactate dehydrogenase (LDH) - tumor marker
ANVISA technical name: LACTATO DESIDROGENASE (LDH) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER
Tick holders, manufacturers or countries below to filter this page.
4registrations
4currently valid
3registration holders
3manufacturers
3countries
IIIrisk class
Related device types
- Radiopaque marker 58
- Immunohistochemistry - general carcinoma markers 24
- Surgical navigation marker 16
- Thyroglobulin (Tg) - tumor marker 15
- Kappa/lambda light chains - tumor marker 13
- Beta human chorionic gonadotropin (beta-hCG) - tumor marker / congenital disorders 13
- Immunohistochemistry - ancillary markers 11
- Immunohistochemistry - lymphoma and leukemia markers 9
- Immunohistochemistry - breast carcinoma markers 8
- Calcitonin - tumor marker 8
- Immunohistochemistry - skin carcinoma and melanoma markers 8
- Lymphoma and leukemia markers 8
- Immunohistochemistry - gastrointestinal tract carcinoma markers 7
- Beta-2 microglobulin - tumor marker 7
- Ferritin - tumor marker 6
- Probes for leukemia and lymphoma markers 5
- Immunohistochemistry - infectious disease markers 5
- Immunohistochemistry - nervous system tumor markers 4
All registrations
| Product | Class | Holder | Published | Status |
|---|---|---|---|---|
| LDH (IFCC)
80254180494 |
III | PHADIA DIAGNOSTICOS LTDA | 05/10/2026 | Until 05/10/2036 |
| Família Lactate Dehydrogenase acc. to IFCC ver.2
10287411812 |
III | ROCHE DIAGNÓSTICA BRASIL LTDA | 21/09/2026 | Until 21/09/2036 |
| Lactate Dehydrogenase2 (LDH2)
80146502431 |
III | ABBOTT LABORATORIOS DO BRASIL LTDA | 27/07/2026 | Until 27/07/2036 |
| Alinity c Lactate Dehydrogenase2 (LDH2)
80146502432 |
III | ABBOTT LABORATORIOS DO BRASIL LTDA | 27/07/2026 | Until 27/07/2036 |